Cytomegalovirus reactivation post-HSCT - a patient case by Prof. Dr. Johan Maertens

Prof. Dr. Johan Maertens shared an in-depth case study of a 59-year-old patient with acute leukemia who underwent haplo-identical stem cell transplantation. The patient faced a series of complex complications, including challenging CMV reactivations, renal impairment, myelotoxicity, and intercurrent bacteremias. A pivotal moment in the patient’s treatment journey came with their enrolment in the Solstice Trial¹, a phase 3 randomized controlled study comparing maribavir to investigator-assigned therapies. 

Find out more about this patient’s case as presented by Prof. Dr. Maertens during the launch webinar of maribavir in Belgium. Watch the video below!

smpc

price